Tenshi Pharmaceuticals Private Limited, a significant shareholder in OneSource Specialty Pharma Limited, has encumbered additional equity shares. As part of a financial arrangement to support Karuna Ventures Private Limited, the promoter group company has pledged a total of 92,36,811 equity shares. This move secures a debt facility of up to INR 1,000 crore, representing approximately 8.06% of the target company’s total issued and paid-up share capital.
Share Pledge Details
Tenshi Pharmaceuticals Private Limited has extended its pledge of equity shares in OneSource Specialty Pharma Limited. This latest encumbrance involves 28,36,811 shares, which were pledged in multiple tranches between January 29, 2026, and March 27, 2026. These shares are held to provide security for zero-coupon, secured, unrated, unlisted, redeemable non-convertible debentures issued by Karuna Ventures Private Limited.
Consolidated Security Position
Following these recent transactions, the aggregate number of pledged shares now stands at 92,36,811. This total represents 8.06% of the total issued and paid-up share capital of OneSource Specialty Pharma Limited. The previous pledges, involving 20,00,000 shares in December 2025 and 44,00,000 shares in January 2026, have been consolidated under this updated security structure to facilitate the financial indebtedness of the group entity.
Commitment and Impact
The pledged shares serve as security for debentures amounting to INR 1,000 crore. While the shares remain with the pledgor, they are encumbered in favor of the debenture trustee to protect the interests of the debenture holders. The equity base of the target company remains stable at 11,45,85,136 paid-up equity shares of INR 1 each, with no change in the shareholding structure arising from this encumbrance.
Source: BSE
